This federal Project Grant award from the National Institutes of Health (NIH) Research Infrastructure Programs (CFDA 93.351) provides $940,821 to Cryocrate LLC, a for-profit biotech company based in Columbia, Missouri, to develop a first-in-class biocompatible and efficient cryopreservation technology platform for cell-based therapeutics in regenerative medicine and drug discovery. The key objectives of this project are: (I) Producing the company's proprietary Odinsol cryopreservation medium...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) provides $306,852 to Mitegen, LLC, a manufacturer of advanced scientific instruments and technologies located in Lansing, New York. The funding will support the development and validation of innovative cryopreservation technology that automates the soaking, cooling, and warming processes for small biological samples such as oocytes and...
The federal Project Grant award of $1,851,874.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public, with a particular emphasis on conditions relevant to military personnel and veterans. The primary awardee, The Henry M. Jackson Foundation for the Advancement of Military Medicine,...
The Defense Health Agency awarded a $1,999,869 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the Hennepin Healthcare Research Institute (HHRI) in Minneapolis, MN. The funding supports the "FROSTBITE MULTICENTER OBSERVATIONAL TRIAL (FROST)" study, which aims to improve health outcomes for military service members and the general public by advancing research on conditions like frostbite. HHRI, a non-profit research organization, will serve...
This federal Project Grant award from the National Science Foundation (NSF) Engineering program (CFDA 47.041) provides $199,867 to the University of Washington to develop an innovative approach for long-term cryopreservation of organs using ice-free vitrification and single-mode electromagnetic resonance (SMER) heating. The project aims to overcome barriers in organ cryopreservation by advancing vitrification and EM heating technologies to enable fast and uniform rewarming of cryopreserved...
This federal Project Grant award from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), provides $818,337 to Vascular Perfusion Solutions Inc. to conduct research on "Extended Limb Stasis in the Encore Tissue Preservation Device". The award period runs from August 15, 2025 to August 14, 2027. The research aims to transform healthcare for military service members, veterans, and the broader public through innovative biomedical...
The federal Project Grant award of $5,099,737.00, awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports a myeloid-targeted novel therapeutic for glomerular diseases. The award, with a performance period from July 1, 2025 to June 30, 2029, was granted to 149 Bio LLC, a for-profit organization located in Miami, Florida. The funded research aims to transform healthcare for military service members, veterans, and the broader public...
The federal Project Grant award, with ID HT94252510624, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The $872,811.00 grant was awarded on Aug 1, 2025 to Luna Labs USA LLC, a small business manufacturer and research and development firm based in Charlottesville, Virginia. The grant supports Luna Labs' development of an "OCULAR PUNCTURE TEARDROP IMMUNOASSAY CASSETTE" - an advanced medical technology for the military....
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $660,000.00 in funding to Nucyrna Therapeutics Inc. in Framingham, MA to develop a SOD1-targeting iRNASO oligonucleotide drug candidate with improved efficacy and safety compared to tofersen. The award has a performance period from July 1, 2025 to June 30, 2027. The Military Medical Research and Development program supports advanced biomedical research...
The Defense Health Agency awarded Nushores Biosciences LLC a $582,000 Project Grant under the Military Medical Research and Development program (CFDA 12.420) on February 15, 2025. The grant supports the development of an "Electrolysis Assisted Catalytic Oxygen Gas Generator for Battlefield Use". This project grant aims to create an innovative medical technology with direct applications in military environments, which aligns with the program's broader mission of improving health...